110 likes | 297 Views
“Herpes Zoster (Shingles) - Pipeline Review, H2 2014”, provides an overview of the Herpes Zoster (Shingles)s therapeutic pipeline. For more details : http://goo.gl/bm9QGG
E N D
Aarkstore - Hepatitis A - Pipeline Review, H1 2014 www.aarkstore.com
Summary “Hepatitis A - Pipeline Review, H1 2014”, provides an overview of the Hepatitis As therapeutic pipeline. This Market Research Report provides comprehensive information on the therapeutic development for Hepatitis A, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Hepatitis A and special features on late-stage and discontinued projects. www.aarkstore.com www.aarkstore.com
Scope - The report provides a snapshot of the global therapeutic landscape of Hepatitis A- The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities - The report reviews key players involved in the therapeutics development for Hepatitis A and enlists all their major and minor projects- The report summarizes all the dormant and discontinued pipeline projects - A review of the Hepatitis A products under development by companies and universities/research institutes based on information derived from company and industry-specific sources- Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages- A detailed assessment of monotherapy and combination therapy pipeline projects- Coverage of the Hepatitis A pipeline on the basis of target, MoA, route of administration and molecule type www.aarkstore.com
Reasons to buy - Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage- Develop strategic initiatives by understanding the focus areas of leading companies- Identify and understand important and diverse types of therapeutics under development for Acute Heart Failure- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline- Devise corrective measures for pipeline projects by understanding Acute Heart Failure pipeline depth and focus of Indication therapeutics- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope www.aarkstore.com
Table of Contents IntroductionREPORT COVERAGEHepatitis A OverviewTherapeutics DevelopmentPipeline Products for Hepatitis A - OverviewPipeline Products for Hepatitis A - Comparative AnalysisHepatitis A - Therapeutics under Development by CompaniesHepatitis A - Therapeutics under Investigation by Universities/InstitutesHepatitis A - Pipeline Products GlanceLate Stage ProductsEarly Stage ProductsUnknown Stage Products www.aarkstore.com
List Of Tables Number of Products under Development for Hepatitis A, H1 2014Number of Products under Development for Hepatitis A - Comparative Analysis, H1 2014Number of Products under Development by Companies, H1 2014Number of Products under Investigation by Universities/Institutes, H1 2014Comparative Analysis by Late Stage Development, H1 2014Comparative Analysis by Early Stage Development, H1 2014Comparative Analysis by Unknown Stage Development, H1 2014Products under Development by Companies, H1 2014Products under Investigation by Universities/Institutes, H1 2014Hepatitis A - Pipeline by iQur Ltd., H1 2014 www.aarkstore.com
List Of Figures Number of Products under Development for Hepatitis A, H1 2014Number of Products under Development for Hepatitis A - Comparative Analysis, H1 2014Number of Products under Development by Companies, H1 2014Comparative Analysis by Early Stage Products, H1 2014Assessment by Monotherapy Products, H1 2014Number of Products by Top 10 Molecule Type, H1 2014Number of Products by Stage and Top 10 Molecule Type, H1 2014 22 www.aarkstore.com
Related Market Research reports: • Corticosteroid-Responsive Dermatoses - Pipeline Review, H1 2014 • Hematological Tumor - Pipeline Review, H1 2014 • Inflammation - Pipeline Review, H1 2014 • Opioid Induced Side Effects - Pipeline Review, H1 2014 • Skin Infections - Pipeline Review, H1 2014 www.aarkstore.com
Related Market Research reports: • Restenosis - Pipeline Review, H1 2014 • Tauopathies - Pipeline Review, H1 2014 • Nasopharyngitis (Common Cold) - Pipeline Review, H1 2014 • Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome) - Pipeline Review, H1 2014 • Chemotherapy Induced Peripheral Neuropathy - Pipeline Review, H1 2014 www.aarkstore.com
Aarkstore - Hepatitis A - Pipeline Review, H1 2014 www.aarkstore.com
Contact Us Office Office No. - 809, 8th Floor, B-Wing, Mahaavir Icon, Plot No.- 89 & 90, Sector-15, CBD-Belapur, Navi Mumbai – 400614, Maharashtra, India. 24/7 Online Support: +91 9987295242 General Inquiries : +91 - 22 2756 4953 You Can Visit : http://www.aarkstore.com OR Mail us at : contact@aarkstore.com Blog : http://www.aarkstore.com/blog/ Conference : http://conference.aarkstore.com/ News : http://www.aarkstore.com/news www.aarkstore.com